These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13275752)

  • 1. Long-term treatment of some arteriopathies with tromexan.
    CASTRO CM; STRITZLER G
    Angiology; 1955 Oct; 6(5):442-61. PubMed ID: 13275752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of anticoagulants in dermatology; use of tromexan (ethyl ester of di-4-hydroxy-coumarinyl acetic acid) in ulcus cruris in dystrophy with thrombophlebitis and in related conditions].
    PANCONESI E
    Rass Dermatol Sifilogr; 1951; 4(2):74-105. PubMed ID: 14892261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolonged treatment of peripheral arterial diseases with Tromexan].
    LANFRANCHI W; DEGNI M
    Arq Bras Med; 1960; 50():499-502. PubMed ID: 14462031
    [No Abstract]   [Full Text] [Related]  

  • 4. Puerperal thrombosis, treatment with tromexan, control of prothrombin activity according to Pedrazzini, Salvidio and F. Koller.
    SCHELLENBERG W
    Praxis; 1953 Jul; 42(29):599-601. PubMed ID: 13088594
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethyl biscoumacetate (tromexan) in coronary artery disease.
    POLLITZER RS
    J S C Med Assoc; 1953 Mar; 49(3):66-8. PubMed ID: 13045283
    [No Abstract]   [Full Text] [Related]  

  • 7. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 8. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
    BURNS JJ; WEINER M; SIMSON G; BRODIE BB
    J Pharmacol Exp Ther; 1953 May; 108(1):33-41. PubMed ID: 13053419
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombotic diseases, especially treatment with tromexan].
    LINDAHL O
    Sven Lakartidn; 1956 Jan; 53(4):185-98. PubMed ID: 13311786
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulant therapy with tromexan].
    GARCIA TURIELLA R; GASPARY FV; TUERO PR; FERRER J
    Prensa Med Argent; 1953 Aug; 40(32):2093-2103. PubMed ID: 13088693
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tromexan therapy of thrombophlebitis].
    VUILLEUMIER P
    Praxis; 1952 Aug; 41(35):758-60. PubMed ID: 13003888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant therapy; tromexan and G-23350].
    MAROIS A; BROSSEAU C
    Laval Med; 1955 Sep; 20(7):940-51. PubMed ID: 13279212
    [No Abstract]   [Full Text] [Related]  

  • 13. Further pharmacologic aspects of tromexan (pelantan or ethyl biscumacetate).
    GRUBER CM; LEE KS; RIEDERS F
    Arch Int Pharmacodyn Ther; 1952; 90(4):488-97. PubMed ID: 12986946
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control].
    DELLA SANTA R
    Helv Med Acta Suppl; 1952; 19(28):1-64. PubMed ID: 13044126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with tromexan].
    WICKE G
    Arztl Wochensch; 1953 Aug; 8(33):782-8. PubMed ID: 13080079
    [No Abstract]   [Full Text] [Related]  

  • 16. [Real or apparent value of tromexan].
    HALSE T
    Dtsch Med Wochenschr; 1952 Dec; 77(52):1634-6. PubMed ID: 13043368
    [No Abstract]   [Full Text] [Related]  

  • 17. The coagulation defect caused by tromexan therapy.
    DOUGLAS AS
    Clin Sci; 1955 Nov; 14(4):601-13. PubMed ID: 13270444
    [No Abstract]   [Full Text] [Related]  

  • 18. Tromexan and dicoumarol.
    ILLINGWORTH DG
    Br Med J; 1951 Sep; 2(4732):646-8. PubMed ID: 14869675
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials with a new anticoagulant; tromexan].
    MILANES B; HERNANDEZ A; PEREZ STABLE E
    Rev Cubana Cardiol; 1951; 12(4):141-50. PubMed ID: 12994207
    [No Abstract]   [Full Text] [Related]  

  • 20. Mode of action of tromexan.
    HUNTER RB; TUDHOPE GR
    Lancet; 1953 Apr; 1(6765):821-3. PubMed ID: 13036185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.